 |
|
|
| |
Safety and pharmacokinetics of bepirovirsen, delivered
subcutaneously by vial, or prefilled syringe fitted with a
safety syringe device in healthy adult participants, and
syringe device ease of use: A randomised Phase 1 trial
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Poonam Shah1, Amir S. Youssef2, Maxwell Hu3, Helene Plein4, Sarah Mole1, Abhishek Roy5, Ravi T5, Magdalena Blazejczyk6, Rachel Green7, Wendy Cross1, Brian Spears8, Samuel Pak9, Rejbinder Kaur1, Ahmed Nader2, Dickens Theodore10, Marjan Hezareh4
1GSK, Stevenage, UK; 2GSK, Collegeville, PA, USA; 3GSK, Shanghai, China; 4GSK, London, UK; 5GSK, Bangalore, India; 6GSK, Warsaw, Poland; 7GSK, Ware, UK; 8PPD, Austin, TX, USA; 9PPD, Las Vegas, NV, USA; 10GSK, Durham, NC, USA
|
| |
|
|
|
|
|
